BridgeBio Pharma Inc. is a biotechnology company focused on discovering and developing transformative medicines for patients with genetic diseases. With a diverse pipeline of innovative therapies, backed by a team of experienced scientists and clinicians, BridgeBio aims to improve the lives of those affected by rare genetic conditions.
Notification